F-STAR THERAPEUTICS

F-Star Therapeutics is a biopharmaceutical company dedicated to developing novel bispecific antibody products that provide a significant improvement over the current standard of care. Given its strong patent position, it is the only biopharmaceutical company with the ability to create and develop Fcab:tm: antibody fragments, and bispecific antibodies, by modifying the constant region of an antibody. In particular, F-starโs Modular Antibody Technology:tm: enables rapid discovery and development... of bispecific antibodies by introducing additional binding sites to the constant region of an antibody and offers unprecedented ease in the development and manufacturing of bispecific monoclonal antibodies. Using the Modular Antibody Technology, F-star generates bispecific antibodies (mAb2:tm:) that possess the favourable characteristics of traditional monoclonal antibodies, without the production challenges often associated with other antibody formats. F-star is now applying its proprietary technology to the development of a pipeline of product candidates. Since its founding in 2006 the company has secured funding and support from leading VC investors: Aescap Venture, Atlas Venture, Novo Ventures and TVM Capital; as well as from renowned strategic corporate investors: Merck Serono Ventures, MP Healthcare Venture Management and SR One. In 2013, F-star established an asset-centric vehicle structure through the formation of F-star Alpha Ltd., which included out-licensing of FS102 from F-star to F-star Alpha Ltd. In October 2014 Bristol-Myers Squibb obtained an exclusive option to buy F-star Alpha. In addition the company has alliances with Boehringer Ingelheim and Merck Serono, each covering multiple targets. In 2011, F-star was selected by FierceBiotech as one of the Fierce 15 winners. F-star currently employs over 35 people at its research site in Cambridge, UK.
F-STAR THERAPEUTICS
Industry:
Biopharma Biotechnology Pharmaceutical
Founded:
2006-01-01
Address:
Cambridge, Cambridgeshire, United Kingdom
Country:
United Kingdom
Website Url:
http://www.f-star.com
Total Employee:
51+
Status:
Active
Contact:
+43 (0)-72055-4215
Email Addresses:
[email protected]
Total Funding:
137.29 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Apple Mobile Web Clips Icon WordPress Domain Not Resolving Wordpress Plugins Nginx Sitelinks Search Box
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
Date | Company | Article | Price |
---|---|---|---|
2020-11-20 | Spring Bank Pharmaceuticals | Spring Bank Pharmaceuticals acquired by F-Star Therapeutics | 30 M USD |
Investors List
Aescap Venture
Aescap Venture investment in Post-IPO Equity - F-Star Therapeutics
Atlas Venture
Atlas Venture investment in Post-IPO Equity - F-Star Therapeutics
SR One
SR One investment in Post-IPO Equity - F-Star Therapeutics
M Ventures
M Ventures investment in Post-IPO Equity - F-Star Therapeutics
M Ventures
M Ventures investment in Series A - F-Star Therapeutics
Aescap Venture
Aescap Venture investment in Series A - F-Star Therapeutics
MP Healthcare Venture Management
MP Healthcare Venture Management investment in Series A - F-Star Therapeutics
SR One
SR One investment in Series A - F-Star Therapeutics
Atlas Venture
Atlas Venture investment in Series A - F-Star Therapeutics
TVM Capital
TVM Capital investment in Series A - F-Star Therapeutics
Key Employee Changes
Date | New article |
---|---|
2022-03-01 | F-star Therapeutics Appoints James Sandy as Chief Development Officer |
Official Site Inspections
http://www.f-star.com Semrush global rank: 4.61 M Semrush visits lastest month: 2.2 K
- Host name: 160.89.214.35.bc.googleusercontent.com
- IP address: 35.214.89.160
- Location: Mountain View United States
- Latitude: 37.4043
- Longitude: -122.0748
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94043

More informations about "F-Star Therapeutics"
F-star - Wikipedia
F-star Biotechnology Ltd. is a biotechnology company, founded in Vienna in 2006, [1] with a current main research site in Cambridge, UK.The company is focused in developing bispecific โฆSee details»
Home - F-star Therapeutics Inc.
F-star is a clinical stage biotech developing next generation immunotherapies to transform the lives of patients with cancer. We are developing transformational cancer immunotherapies for patients who have few remaining options.See details»
F-star Company Profile | Management and Employees List
F-star Profile and History F-star is a clinical-stage biopharmaceutical company developing tetravalent bispecific antibodies for a transformation in cancer therapy. By developing โฆSee details»
About - F-star Therapeutics Inc.
Pharmaceutical Partnerships. F-starโs platform has been validated through partnerships for over a decade. We have collaboration and licensing agreements with many leading biopharma companies to research, develop, and โฆSee details»
F-Star Therapeutics - Crunchbase Company Profile
F-star is now applying its proprietary technology to the development of a pipeline of product candidates. Since its founding in 2006 the company has secured โฆSee details»
Sarah Batey - F-star Therapeutics Inc.
I lead the portfolio and project management group at F-star, this involves working with many different teams across the organization to ensure that the projects and pipeline are delivered โฆSee details»
F-star, an invoX company - Crunchbase
Organization. F-star, an invoX company . Connect to CRM . Save . Summary. People. Technology. Signals & News. ... Find More Contacts for F-star, an invoX company. Protected โฆSee details»
F-star - Overview, News & Similar companies | ZoomInfo.com
Mar 6, 2023 F-star is a clinical-stage biopharmaceutical company developing tetravalent bispecific antibodies for a transformation in cancer therapy. By develo ping medicines that โฆSee details»
F-Star Therapeutics - Funding, Financials, Valuation & Investors
F-Star Therapeutics is registered under the ticker NASDAQ:FSTX . F-Star Therapeutics is funded by 8 investors. Aescap Venture and Atlas Venture are the most recent investors. F-Star โฆSee details»
F-star - Products, Competitors, Financials, Employees, โฆ
F-star. Frequently Asked Questions (FAQ) When was F-star founded? F-star was founded in 2002. Where is F-star's headquarters? F-star's headquarters is located at Eddeva B920, โฆSee details»
f-star Biotechnologische Forschungs- und Entwicklungsges.m.b.H.
Organization type RDM biotech/pharma Region Vienna Cluster LISAvienna Focus human health Details. ENSEMO GmbH. Organization type RDM biotech/pharma Region Lower Austria โฆSee details»
Spring Bank Pharmaceuticals and F-star Therapeutics Agree to โฆ
Jul 29, 2020 Mintz Levin and Mills & Reeve are serving as legal counsel to F-star.Management and Organization Effective as of the closing of the transaction, Eliot Forster, Ph.D., MBA, will โฆSee details»
F Star - Crunchbase Company Profile & Funding
Organization. F Star . Connect to CRM . Save . Summary. People. Signals & News. About. ... F Star provides IT consulting, system planning and introduction support from the standpoint of โฆSee details»
What is F-Star? Company Culture, Mission, Values | Glassdoor
See what employees say it's like to work at F-Star. Salaries, reviews, and more - all posted by employees working at F-Star.See details»
F-star Therapeutics Reports Full-Year 2020 Financial Results and ...
F-star is a clinical-stage biopharmaceutical company developing tetravalent bispecific antibodies for a paradigm shift in cancer therapy. By developing medicines that seek to block tumor โฆSee details»
Street Transvestite Action Revolutionaries - Wikipedia
Street Transvestite Action Revolutionaries (STAR) was a gay, gender non-conforming, and transvestite street activist organization founded in 1970 by Sylvia Rivera and Marsha P. โฆSee details»
F Star - Contacts, Employees, Board Members, Advisors & Alumni
F Star provides IT consulting, system planning and introduction support from the standpoint of financial institutions and customers. Search Crunchbase. Start Free Trial . Chrome Extension. โฆSee details»
Careers - F-star Therapeutics Inc.
EOE Statement: F-star is an Equal Opportunity Employer. By embracing diverse skills, perspectives, and ideas, we choose to lead. All qualified applicants will receive consideration โฆSee details»
Jฤnis Timma, Former NBA Hopeful, Dead At 32 - HuffPost
3 days ago Latvian basketball player Jฤnis Timma, who was previously a member of the Orlando Magicโs minor league organization, was found dead Tuesday at age 32. Gary Bassing via โฆSee details»
Press Releases - F-star Therapeutics Inc.
Aug 4, 2022 F-star Therapeutics to Host Fourth Quarter and Full-Year 2021 Financial Results Conference Call on March 14, 2022 » Mar 1, 2022 F-star Therapeutics Appoints James Sandy โฆSee details»